|
|
|
Eye Disease Clinical Trials |
|
Thank you for your interest in clinical trials for Eye Disease
Please click "Search" to find Eye Disease clinical trials and medical research studies.
If you receive too many study listings you may enter your zip code to find the locations closest to you.
|
|
|
|
|
Results from Clinical Connection:
|
|
Your Search Returned No Results. |
|
|
|
|
|
Results from other databases:
|
|
|
|
Your search returned 86 studies:
- Allergic Eye Disease Tear Mediators - NCT00609128-53705
Conditions: Allergic Eye Disease
Location: Madison, WI
- Analysis of Human Tear Proteins - NCT00453258-80045
Conditions: Eye Disease
Location: Aurora, CO
- Analysis of Human Tear Proteins in Children - NCT00473278-80218
Conditions: Eye Disease
Location: Denver, CO
- Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder - NCT00755040-37064A
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases
Location: Nashville, TN
- Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder - NCT00755040-37064B
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases
Location: Nashville, TN
- Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder - NCT00755040-37232
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Diseases
Location: Nashville, TN
- Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye Disease - NCT00667004-92618
Conditions: Dry Eye Disease
Location: Irvine, CA
- Evaluation and Treatment of People With Eye Diseases - NCT00708955-20892
Conditions: Eye Diseases
Location: Bethesda, MD
- Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z® - NCT00799682-11554
Conditions: Dry Eye Disease
Location: East Meadow, NY
- Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z® - NCT00799682-11563
Conditions: Dry Eye Disease
Location: Lynbrook, NY
- Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z® - NCT00799682-11570
Conditions: Dry Eye Disease
Location: Rockville Centre, NY
- Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z® - NCT00799682-11581
Conditions: Dry Eye Disease
Location: Valley Stream, NY
- Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z® - NCT00799682-11790
Conditions: Dry Eye Disease
Location: Stony Brook, NY
- Immune Responses to Antigens in Non-infectious Eye Inflammatory Diseases - NCT00357071-20892
Conditions: Eye Diseases
Location: Bethesda, MD
- Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis - NCT00407043-11563
Conditions: Dry Eye Disease - Keratoconjunctivitis Sicca
Location: Lynbrook, NY
- RBD Longitudinal as Prognostic for PD - NCT00817726-77030
Conditions: Rapid Eye Movement Sleep Behavior Disorder - Parkinson's Disease
Location: Houston, TX
- Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease - NCT00758784-92618
Conditions: Dry Eye Disease
Location: Irvine, CA
- Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration - NCT00877032-49007
Conditions: Age-Related Maculopathy - Age-Related Maculopathies - Eye Diseases - Retinal Degeneration - Macular Degeneration
Location: Kalamazoo, MI
- Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration - NCT00877032-78217
Conditions: Age-Related Maculopathy - Age-Related Maculopathies - Eye Diseases - Retinal Degeneration - Macular Degeneration
Location: San Antonio, TX
- Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration - NCT00877032-84106
Conditions: Age-Related Maculopathy - Age-Related Maculopathies - Eye Diseases - Retinal Degeneration - Macular Degeneration
Location: Salt Lake City, UT
- Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration - NCT00877032-85013
Conditions: Age-Related Maculopathy - Age-Related Maculopathies - Eye Diseases - Retinal Degeneration - Macular Degeneration
Location: Phoenix, AZ
- Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration - NCT00877032-90301
Conditions: Age-Related Maculopathy - Age-Related Maculopathies - Eye Diseases - Retinal Degeneration - Macular Degeneration
Location: Inglewood, CA
- Study of Sentinel Lymph Node Biopsy for Conjunctival Melanoma and Sebaceous Cell Carcinoma of the Eyelid - NCT00386906-77030
Conditions: Eye Disease - Melanoma
Location: Houston, TX
- Study to Evaluate Eye Function in Patients Taking Linezolid for Two Months or Greater - NCT00359632-15206
Conditions: Optic Nerve Diseases
Location: Pittsburgh, PA
- Study to Evaluate Eye Function in Patients Taking Linezolid for Two Months or Greater - NCT00359632-15212
Conditions: Optic Nerve Diseases
Location: Pittsburgh, PA
- Study to Evaluate Eye Function in Patients Taking Linezolid for Two Months or Greater - NCT00359632-19027
Conditions: Optic Nerve Diseases
Location: Elkins Park, PA
- Study to Evaluate Eye Function in Patients Taking Linezolid for Two Months or Greater - NCT00359632-19102
Conditions: Optic Nerve Diseases
Location: Philadelphia, PA
- Study to Evaluate Eye Function in Patients Taking Linezolid for Two Months or Greater - NCT00359632-19140
Conditions: Optic Nerve Diseases
Location: Philadelphia, PA
- Study to Evaluate Eye Function in Patients Taking Linezolid for Two Months or Greater - NCT00359632-48201
Conditions: Optic Nerve Diseases
Location: Detroit, MI
- Study to Evaluate Eye Function in Patients Taking Linezolid for Two Months or Greater - NCT00359632-48202
Conditions: Optic Nerve Diseases
Location: Detroit, MI
- Study to Evaluate Eye Function in Patients Taking Linezolid for Two Months or Greater - NCT00359632-55455
Conditions: Optic Nerve Diseases
Location: Minneapolis, MN
- Study to Evaluate Eye Function in Patients Taking Linezolid for Two Months or Greater - NCT00359632-70121
Conditions: Optic Nerve Diseases
Location: New Orleans, LA
- Study to Evaluate Eye Function in Patients Taking Linezolid for Two Months or Greater - NCT00359632-72401
Conditions: Optic Nerve Diseases
Location: Jonesboro, AR
- Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau Syndrome - NCT00673816-20892
Conditions: Von Hippel-Lindau Syndrome
Location: Bethesda, MD
- TearLab Core Validation Study - NCT00848198-28204
Conditions: Dry Eye Disease
Location: Charlotte, NC
- TearLab Core Validation Study - NCT00848198-40202
Conditions: Dry Eye Disease
Location: Louisville, KY
- TearLab Core Validation Study - NCT00848198-43210
Conditions: Dry Eye Disease
Location: Columbus, OH
- TearLab Core Validation Study - NCT00848198-63017A
Conditions: Dry Eye Disease
Location: Chesterfield, MO
- TearLab Core Validation Study - NCT00848198-63017B
Conditions: Dry Eye Disease
Location: Kansas City, MO
- TearLab Core Validation Study - NCT00848198-92130
Conditions: Dry Eye Disease
Location: San Diego, CA
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-02114
Conditions: Dry Eye Disease
Location: Boston, MA
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-06002
Conditions: Dry Eye Disease
Location: Bloomfield, CT
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-06518
Conditions: Dry Eye Disease
Location: Hamden, CT
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-10029
Conditions: Dry Eye Disease
Location: New York, NY
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-11563
Conditions: Dry Eye Disease
Location: Lynbrook, NY
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-11793
Conditions: Dry Eye Disease
Location: Wantagh, NY
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-12054
Conditions: Dry Eye Disease
Location: Delmar, NY
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-17601
Conditions: Dry Eye Disease
Location: Lancaster, PA
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-19148
Conditions: Dry Eye Disease
Location: Philadelphia, PA
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-22102
Conditions: Dry Eye Disease
Location: McLean, VA
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-23502
Conditions: Dry Eye Disease
Location: Norfolk, VA
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-28204
Conditions: Dry Eye Disease
Location: Charlotte, NC
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-29464
Conditions: Dry Eye Disease
Location: Mount Pleasant, SC
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-33176
Conditions: Dry Eye Disease
Location: Miami, FL
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-33321
Conditions: Dry Eye Disease
Location: Tamarac, FL
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-33603
Conditions: Dry Eye Disease
Location: Tampa, FL
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-34209
Conditions: Dry Eye Disease
Location: Bradenton, FL
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-34613
Conditions: Dry Eye Disease
Location: Brooksville, FL
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-40217
Conditions: Dry Eye Disease
Location: Louisville, KY
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-44115
Conditions: Dry Eye Disease
Location: Cleveland, OH
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-46202
Conditions: Dry Eye Disease
Location: Indianapolis, IN
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-46260
Conditions: Dry Eye Disease
Location: Indianapolis, IN
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-52245
Conditions: Dry Eye Disease
Location: Iowa City, IA
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-55404
Conditions: Dry Eye Disease
Location: Minneapolis, MN
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-57701
Conditions: Dry Eye Disease
Location: Rapid City,
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-60108
Conditions: Dry Eye Disease
Location: Bloomingdale, IL
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-60169
Conditions: Dry Eye Disease
Location: Hoffman Estates, IL
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-63090
Conditions: Dry Eye Disease
Location: Washington, MO
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-63131A
Conditions: Dry Eye Disease
Location: St Louis, MO
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-63131B
Conditions: Dry Eye Disease
Location: Des Peres, MT
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-64111
Conditions: Dry Eye Disease
Location: Kansas City, MO
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-77583
Conditions: Dry Eye Disease
Location: Rosharon, TX
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-78209
Conditions: Dry Eye Disease
Location: San Antonio, TX
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-78221
Conditions: Dry Eye Disease
Location: San Antonio, TX
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-78731
Conditions: Dry Eye Disease
Location: Austin, TX
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-79904
Conditions: Dry Eye Disease
Location: El Paso, TX
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-89052
Conditions: Dry Eye Disease
Location: Henderson, NV
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-90302
Conditions: Dry Eye Disease
Location: Inglewood, CA
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-90505
Conditions: Dry Eye Disease
Location: Torrance, CA
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-90701
Conditions: Dry Eye Disease
Location: Artesia, CA
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-91345
Conditions: Dry Eye Disease
Location: Mission Hills, CA
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-92663
Conditions: Dry Eye Disease
Location: Newport Beach, CA
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-94954
Conditions: Dry Eye Disease
Location: Petaluma, CA
- The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease - NCT00831662-95670
Conditions: Dry Eye Disease
Location: Ranchero Cordova, CA
- Tissue Studies of Human Eye Diseases - NCT00001310-20892
Conditions: Conjunctival Disease - Corneal Disease - Eye Disease - Uveitis - Vitreoretinopathy, Proliferative
Location: Bethesda, MD
- Validation of Computerized Vision-Targeted Quality-of-Life Questionnaires - NCT00678860-20892
Conditions: Eye Disease
Location: Bethesda, MD
|
|
|
|
|
Didn't find what you were looking for? Try these alternatives:
Become A Member: To be notified of upcoming clinical trials in your
area please create a free member account.
Browse Studies: If you would like to browse all featured clinical trials
please Browse Studies.
Message Board: Join the discussion in our Health
and Clinical Trials Message Board.
|
|
|